Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 200 shares, a drop of 98.9% from the November 15th total of 18,600 shares. Based on an average trading volume of 286,800 shares, the short-interest ratio is currently 0.0 days.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on LZAGY shares. Redburn Atlantic upgraded Lonza Group to a “strong-buy” rating in a report on Wednesday, November 27th. The Goldman Sachs Group upgraded shares of Lonza Group to a “strong-buy” rating in a research note on Wednesday, October 9th.
View Our Latest Research Report on LZAGY
Lonza Group Price Performance
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Recommended Stories
- Five stocks we like better than Lonza Group
- What Investors Need to Know About Upcoming IPOs
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- ESG Stocks, What Investors Should Know
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- How to trade using analyst ratings
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.